🔴 Rezolute Inc is trading 5.3% down today on post-rally consolidation and broader market weakness

Rezolute Inc is trading at $3.87 (5.3% down) as the stock undergoes consolidation following a sharp multi-day rally driven by positive Phase 3 ersodetug trial data earlier in June.

• The pullback appears to be a normal technical correction for the volatile small-cap biotech, as there are no new company-specific headlines or SEC filings as of June 9, 2026.
• The downward movement is being exacerbated by a generally weaker tone across the broader market.
• Shares remain significantly higher for the month following the successful clinical trial results released earlier in the period.